RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
144 hedge funds and large institutions have $1.23B invested in Revance Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 33 reducing their positions, and 13 closing their positions.
Holders
144
Holders Change
+14
Holders Change %
+10.77%
% of All Funds
2.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
27
Increased
64
Reduced
33
Closed
13
Calls
$5.45M
Puts
$1.09M
Net Calls
+$4.36M
Net Calls Change
+$3.57M
Top Buyers
| 1 |
PC
1
Polar Capital
London,
United Kingdom
|
$31.3M |
| 2 |
PAI
2
Palo Alto Investors
Palo Alto,
California
|
$41.6M |
| 3 |
3
AllianceBernstein
Nashville,
Tennessee
|
$68.2M |
| 4 |
4
BlackRock
New York
|
$108M |
| 5 |
5
Jennison Associates
New York
|
$51.9M |
